search

Paul Spagnuolo, a world leader in bioinnovation research, will be honoured for his work on an avocado-derived lipid with potent antileukemia activity with the first LIST International Award in Bioinnovation.

With the LIAB Award, the Luxembourg Institute of Science and Technology (LIST) seeks to connect Luxembourg to world-leading researchers in the fields of biology, ecology, circular economy, health sciences and food sciences. Endowed with 10,000 euros and sponsored by PM-International, a Luxembourg-based nutrition company specialised in premium dietary supplements and health products, the prize will be awarded at the Halle des Poches à Fonte in Belval on November 23 2017 at 19h00.

TOP-FLIGHT CANDIDATES

Earlier this year, LIST launched a call for proposals to the international research community to highlight their innovative work submitted or published after January 1 2014 in domains such as the bioavailability of nutrients, nutrient transport and nutrient effectiveness on a cellular level. More than thirty world-renowned researchers responded to this call.

All applications were reviewed by a jury composed of academics from LIST as well as international experts from renowned universities in the field, such as the University of Groningen in the Netherlands, the University of Applied Sciences Upper Austria, as well as bioinnovation professionals, with a pharmacist and a general medical practitioner, the latter also working at PM-International.

A CANADIAN LAUREATE REWARDED

Among the applications received, it was the outstanding work of Paul Spagnuolo, Associate Professor within the Department of Food Science at the University of Guelph in Canada, which appealed most to the jury members. He was chosen for the prize of 10,000 euros thanks to his paper on anticancer nutraceuticals (nutrients with pharmaceutical properties) published in June 2015 in Cancer Research, a prestigious cancer research journal.

In his article “Targeting Mitochondria with Avocatin B Induces Selective Leukemia Cell Death”, Paul Spagnuolo unveiled his work on Avocatin B, an avocado-derived lipid with potent anti-leukemia activity. Exploring a potential answer to cancer, his article highlights the cell and molecular mechanisms by which Avocatin B selectively targets and eliminates leukemia stem cells. This work, which received much international attention at the time of its publication, has since provided the framework for studies that are now moving Avocatin B into human testing for bioactivity.

Paul Spagnuolo is a renowned researcher in the field. Author of over 30 peer-reviewed publications and a Principal Investigator since March 2012, he has secured more than 2 million dollars in funding from Canadian and international agencies as well from industry. At the University of Guelph since 2016, Paul Spagnuolo runs a laboratory that is uniquely positioned amongst world leaders in food, nutrition and nutraceutical research.

Read more

ArcelorMittal develops 3D-printed ventilator prototype

01-04-2020

Many companies are currently using their innovative capabilities to help alleviate the COVID-19 sanitary crisis. The R&D team of ArcelorMittal has developed a protoype for a 3D-printed ventilator which, if successfully tested, could be produced rapidly.
Read more

COVID-19: Mobilisation of R&D at all levels

01-04-2020

Faced with the global COVID-19 pandemic, institutional and private players in research, development and innovation are stepping forward. The first results are already tangible.
Read more

DigiJourney: tools for digitalisation tailored to SMEs

31-03-2020

As part of the “Digital transformation journey for SMEs” initiative, Luxinnovation collaborates with FundecytPCTEX (ES) and SC IPA SA (RO). The objective is to publish a guide with tools to help other innovation agencies and organisations to drive digitalisation in companies.
Read more

Luxembourg Trade & Investment Offices remain open

27-03-2020

Despite the restrictive measures put in place in a high number of countries across the world to combat the COVID-19 pandemic, all Luxembourg Trade & Investment Offices remain open to companies interested in finding out more about doing business in and with Luxembourg.
Read more

Luxembourg launches unprecedented economic stabilisation programme

27-03-2020

In response to the economic challenges arising from the coronavirus crisis, the Luxembourg government announced on 25 March 2020 the launch of a massive stabilisation programme for the national economy. Measures for a total of €8.8 billion will help companies face the immediate shortage of cash and maintain employment.
Read more

All news

Fermer